Pricing

ORBIMED CAPITAL LLC

0 followers ·
NEW YORK NY Investment Advisor Hedge Fund
13F Summary
Orbimed Capital is based out of New York. Orbimed Capital is a hedge fund Whalewisdom has at least 1 13F filings, 21 13D filings, 65 13G filings, and 4 Form 4 filings

2024-03-31

Top Buys (13F)

Name % Change
JANX Janux Therapeutics I 4.79%
EWTX Edgewise Therapeutic 3.25%
CYTK Cytokinetics Inc 1.95%
GERN Geron Corp. 1.73%
ESPR Esperion Therapeutic 1.5%

2024-03-31

Top Sells (13F)

2024-03-31

13F Holdings Summary

Name $ Change
EWTX Edgewise Therapeutic 11.16%
BIIB Biogen Inc 7.91%
JANX Janux Therapeutics I 6.56%
ELVN Enliven Therapeutics 6.45%
BMRN BioMarin Pharmaceuti 4.55%
All or part of ORBIMED CAPITAL LLC 13F disclosures were filed under a combined 13F through ORBIMED ADVISORS LLC
for 2024-03-31

2024-03-31

13F Activity

Market Value $2.45b, Prior: $2.01b
Inflows (Outflows) as % of Total MV +16.0587%
New Purchases 21 stocks
Added To 11 stocks
Sold out of 0 stocks
Reduced holdings in 9 stocks
Top 10 Holdings % 54.54%
Turnover %[1] 38.18%
Turnover Alt %[2] 3.26%
Time Held Top 20 1.5 quarters
Time Held Top 10 1.2 quarters
Time Held All 1.18 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2024-03-31

13F Sector Allocation Over Time

2024-03-31

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2024-03-31

Portfolio Performance